| Typicality: | 0.438 |
| Saliency: | 0.442 |
| to assess tolerability | 22 | purpose |
| once weekly | 2 | temporal |
| trial → be designed to evaluate → pharmacokinetic | 16 |
| trial → be designed to assess → pharmacokinetic | 15 |
| trial → be designed to assess → pharmacodynamic | 13 |
| trial → be designed to evaluate → pharmacodynamic | 3 |
| negative | neutral | positive |
| 0.022 | 0.878 | 0.099 |
| Raw frequency | 47 |
| Normalized frequency | 0.442 |
| Modifier score | 0.500 |
| Perplexity | 66.303 |